The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Just to drill down a little more, the Auryon has, I mean, far exceeded our expectations. And just curious as I was looking -- you've been taking share,
originally, I think you said in the laser market, now that's moving into the other more mechanical type of devices.
But as you think about the future with less placements and increased utilization, I mean how much utilization do you think you can see persist?
How many procedures are you kind of getting with a given customer versus what you could penetrate with that customer? I was wondering if you
could give us a little more flavor maybe on what we should expect. I know you gave us some numbers, but how that kind of plays out executionally
in the accounts?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
JULY 12, 2022 / 12:00PM, ANGO.OQ - Q4 2022 AngioDynamics Inc Earnings Call
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Okay. And then on AlphaVac $2.2 million in the year, going to $7 million to $9 million going into full market launch with the 18 French. And just
as you think about that step-up from year 1 to year 2, how much of that is with the existing 22 French or is it mostly incremental with the 18 French
and just getting into different parts of the body?
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: And just to kind of wrap it up for me with financial. Just as we think of the August quarter in guidance, you gave the year, but given all the puts
and takes, just wondering if you could give us maybe a little more granularity on how that will look sequentially from May to August?
And then on the tax rate, just -- I don't think you gave tax rate guidance, but if you could help us out, I think you've been averaging in the low 12%,
13% historically on a gap, and is that what we should kind of model going forward?
|
